Cardiovascular disease remains a frequent cause of morbidity and mortality
in industralized countries, particularly in subjects with hypertension, dia
betes mellitus, and dyslipidemia, conditions frequently associated with cen
tral obesity. Identification of early morphological and/or functional alter
ations of the cardiovascular system may help target individuals most likely
to benefit from preventive measures. The literature data and our own exper
ience suggest that parameters that are direct expressions of cardiovascular
damage, can be identified at an early stage. For example, diastolic dysfun
ction may precede the clinical expression of several cardiac diseases, left
ventricular hypertrophy is one of the first manifestations of cardiac invo
lvement in hypertension, central obesity and diabetes mellitus, and a carot
id plaque may point to concomitant coronary artery disease. Other early man
ifestations of cardiovascular involvement are microalbuminuria and endothel
ial dysfunction. Insulin resistance and alterations of the renin-angiotensi
n-aldosterone system play an important physiopathogenic role in the develop
ment of cardiovascular damage in obese subjects, and their association with
risk and cardiovascular disease has been confirmed in numerous studies. Si
nce all these changes generally precede overt clinical manifestations and a
re closely related to cardiovascular morbidity, they may help identify indi
viduals at the highest risk of cardiovascular events. (C) 1999, Medikal Pre
ss.